Pimozide (Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

CAS：2062-78-4
中文别名：匹莫奇特;1-[1-[4,4-二(4-氟苯基)丁基]-4-哌啶]-1,3-二氢-2H-苯并-2-酮;
英文别名：Neoperidole;Pimozidum;McN-JR-6238;Opiran;3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one;1-[1-[4,4-bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one;pimozida;Orap;
分子式：C28H29F2N3O
分子量：461.546
精确质量：461.228
Psa：41.03
Logp：5.7949

RTECS号：DE1750000
MDL号：MFCD00055081
EINECS号：218-171-7
PubChem号：24277923

密度：1.224g/cm3
折射率：1.596
储存条件：2-8ºC

RTECS号：DE1750000
安全说明：S36
WGK Germany：3
危险类别码：R22
危险品运输编码：3249
海关编码：2933990090
危险类别：6.1(b)
包装等级：III
危险品标志：Xn
危险性描述：H302
信号词：Warning
危险标志：GHS07